- IBDEI3I0 ; ; 19-NOV-2015
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
- Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.4,313,0)
- ;;=INTENSIVE CARE^5^36
- ;;^UTILITY(U,$J,358.4,314,0)
- ;;=TELE-HEALTH ICU^9^36
- ;;^UTILITY(U,$J,358.4,315,0)
- ;;=BRAIN^1^37
- ;;^UTILITY(U,$J,358.4,316,0)
- ;;=DIGESTIVE^2^37
- ;;^UTILITY(U,$J,358.4,317,0)
- ;;=ENDOCRINE^3^37
- ;;^UTILITY(U,$J,358.4,318,0)
- ;;=HEART^4^37
- ;;^UTILITY(U,$J,358.4,319,0)
- ;;=LIVER^5^37
- ;;^UTILITY(U,$J,358.4,320,0)
- ;;=LUNGS^6^37
- ;;^UTILITY(U,$J,358.4,321,0)
- ;;=MUSCULOSKELETAL^7^37
- ;;^UTILITY(U,$J,358.4,322,0)
- ;;=OTHER^8^37
- ;;^UTILITY(U,$J,358.4,323,0)
- ;;=POSTOPERATIVE COMPLICATIONS^9^37
- ;;^UTILITY(U,$J,358.4,324,0)
- ;;=SEPSIS^10^37
- ;;^UTILITY(U,$J,358.4,325,0)
- ;;=URINARY TRACT^11^37
- ;;^UTILITY(U,$J,358.4,326,0)
- ;;=NEW PATIENT^2^38
- ;;^UTILITY(U,$J,358.4,327,0)
- ;;=ESTABLISHED PATIENT^1^38
- ;;^UTILITY(U,$J,358.4,328,0)
- ;;=CONSULTATIONS^3^38
- ;;^UTILITY(U,$J,358.4,329,0)
- ;;=BIOPSY/DEBRIDEMENT^1^39
- ;;^UTILITY(U,$J,358.4,330,0)
- ;;=I&D/ASPIRATION^10^39
- ;;^UTILITY(U,$J,358.4,331,0)
- ;;=DESTRUCT-BENIGN/PREMALIG LESIONS^3^39
- ;;^UTILITY(U,$J,358.4,332,0)
- ;;=PARING/CUTTING^16^39
- ;;^UTILITY(U,$J,358.4,333,0)
- ;;=EXCISE BENIGN-SCALP/NECK/HAND/GENITAL/FT^5^39
- ;;^UTILITY(U,$J,358.4,334,0)
- ;;=EXCISE BENIGN-FACE/EAR/NOSE/LIP/LID^4^39
- ;;^UTILITY(U,$J,358.4,335,0)
- ;;=EXCISION BENIGN-TRUNK/ARM/LEG^6^39
- ;;^UTILITY(U,$J,358.4,336,0)
- ;;=EXCISE MALIG-FACE/EAR/NOSE/LIP/LID^7^39
- ;;^UTILITY(U,$J,358.4,337,0)
- ;;=EXCISE MALIG-SCALP/NECK/HAND/GENITAL/FT^8^39
- ;;^UTILITY(U,$J,358.4,338,0)
- ;;=EXCISION MALIG-TRUNK/ARM/LEG^9^39
- ;;^UTILITY(U,$J,358.4,339,0)
- ;;=REPAIR,SIMPLE-SCALP/NECK/TRUNK/EXTREM^21^39
- ;;^UTILITY(U,$J,358.4,340,0)
- ;;=REPAIR,SIMPLE-FACE/EAR/NOSE/LID/LIP^20^39
- ;;^UTILITY(U,$J,358.4,341,0)
- ;;=REPAIR,INTERMED-SCALP/TRUNK/LEG/ARM^19^39
- ;;^UTILITY(U,$J,358.4,342,0)
- ;;=REPAIR,INTERMED-FACE/EAR/NOSE/LID/LIP^17^39
- ;;^UTILITY(U,$J,358.4,343,0)
- ;;=REPAIR,INTERMED-NECK/HAND/GENITAL/FT^18^39
- ;;^UTILITY(U,$J,358.4,344,0)
- ;;=REPAIR-SIMPLE WOUND DEHISCENCE^22^39
- ;;^UTILITY(U,$J,358.4,345,0)
- ;;=NURSING PROCEDURES^14^39
- ;;^UTILITY(U,$J,358.4,346,0)
- ;;=BLOOD^2^39
- ;;^UTILITY(U,$J,358.4,347,0)
- ;;=IV INFUSION^11^39
- ;;^UTILITY(U,$J,358.4,348,0)
- ;;=MEDICATION^12^39
- ;;^UTILITY(U,$J,358.4,349,0)
- ;;=MEDICATION ADMINISTATION^13^39
- ;;^UTILITY(U,$J,358.4,350,0)
- ;;=PARACENTESIS^15^39
- ;;^UTILITY(U,$J,358.4,351,0)
- ;;=OTHER^23^39
- ;;^UTILITY(U,$J,358.4,352,0)
- ;;=ABDOMINAL PAIN^1^40
- ;;^UTILITY(U,$J,358.4,353,0)
- ;;=AFTERCARE POST SURGERY^2^40
- ;;^UTILITY(U,$J,358.4,354,0)
- ;;=BENIGN LESIONS OF SKIN^3^40
- ;;^UTILITY(U,$J,358.4,355,0)
- ;;=BREAST-FEMALE^5^40
- ;;^UTILITY(U,$J,358.4,356,0)
- ;;=BREAST-MALE^6^40
- ;;^UTILITY(U,$J,358.4,357,0)
- ;;=CARDIOVASCULAR^7^40
- ;;^UTILITY(U,$J,358.4,358,0)
- ;;=CIRRHOSIS^8^40
- ;;^UTILITY(U,$J,358.4,359,0)
- ;;=COLITIS^9^40
- ;;^UTILITY(U,$J,358.4,360,0)
- ;;=CROHN'S^10^40
- ;;^UTILITY(U,$J,358.4,361,0)
- ;;=DIVERTICULITIS^11^40
- ;;^UTILITY(U,$J,358.4,362,0)
- ;;=DIVERTICULOSIS^12^40
- ;;^UTILITY(U,$J,358.4,363,0)
- ;;=ENT^13^40
- ;;^UTILITY(U,$J,358.4,364,0)
- ;;=GANGLION^14^40
- ;;^UTILITY(U,$J,358.4,365,0)
- ;;=GANGRENE^15^40
- ;;^UTILITY(U,$J,358.4,366,0)
- ;;=GENERAL SIGNS/SYMPTOMS^16^40
- ;;^UTILITY(U,$J,358.4,367,0)
- ;;=GI^17^40
- ;;^UTILITY(U,$J,358.4,368,0)
- ;;=GYN^18^40
- ;;^UTILITY(U,$J,358.4,369,0)
- ;;=HEMORRHOIDS^19^40
- ;;^UTILITY(U,$J,358.4,370,0)
- ;;=INTESTINAL ABSCESS^20^40
- ;;^UTILITY(U,$J,358.4,371,0)
- ;;=LACERATION^21^40
- ;;^UTILITY(U,$J,358.4,372,0)
- ;;=MALIGNANT SKIN LESION^23^40
- ;;^UTILITY(U,$J,358.4,373,0)
- ;;=MELANOMA^24^40
- ;;^UTILITY(U,$J,358.4,374,0)
- ;;=MERKEL CELL CARCINOMA^25^40
- ;;^UTILITY(U,$J,358.4,375,0)
- ;;=OPEN WOUND^26^40
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3I0 3979 printed Mar 13, 2025@21:54:01 Page 2
- IBDEI3I0 ; ; 19-NOV-2015
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
- +2 if 'DIFQR(358.4)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.4,313,0)
- +2 ;;=INTENSIVE CARE^5^36
- +3 ;;^UTILITY(U,$J,358.4,314,0)
- +4 ;;=TELE-HEALTH ICU^9^36
- +5 ;;^UTILITY(U,$J,358.4,315,0)
- +6 ;;=BRAIN^1^37
- +7 ;;^UTILITY(U,$J,358.4,316,0)
- +8 ;;=DIGESTIVE^2^37
- +9 ;;^UTILITY(U,$J,358.4,317,0)
- +10 ;;=ENDOCRINE^3^37
- +11 ;;^UTILITY(U,$J,358.4,318,0)
- +12 ;;=HEART^4^37
- +13 ;;^UTILITY(U,$J,358.4,319,0)
- +14 ;;=LIVER^5^37
- +15 ;;^UTILITY(U,$J,358.4,320,0)
- +16 ;;=LUNGS^6^37
- +17 ;;^UTILITY(U,$J,358.4,321,0)
- +18 ;;=MUSCULOSKELETAL^7^37
- +19 ;;^UTILITY(U,$J,358.4,322,0)
- +20 ;;=OTHER^8^37
- +21 ;;^UTILITY(U,$J,358.4,323,0)
- +22 ;;=POSTOPERATIVE COMPLICATIONS^9^37
- +23 ;;^UTILITY(U,$J,358.4,324,0)
- +24 ;;=SEPSIS^10^37
- +25 ;;^UTILITY(U,$J,358.4,325,0)
- +26 ;;=URINARY TRACT^11^37
- +27 ;;^UTILITY(U,$J,358.4,326,0)
- +28 ;;=NEW PATIENT^2^38
- +29 ;;^UTILITY(U,$J,358.4,327,0)
- +30 ;;=ESTABLISHED PATIENT^1^38
- +31 ;;^UTILITY(U,$J,358.4,328,0)
- +32 ;;=CONSULTATIONS^3^38
- +33 ;;^UTILITY(U,$J,358.4,329,0)
- +34 ;;=BIOPSY/DEBRIDEMENT^1^39
- +35 ;;^UTILITY(U,$J,358.4,330,0)
- +36 ;;=I&D/ASPIRATION^10^39
- +37 ;;^UTILITY(U,$J,358.4,331,0)
- +38 ;;=DESTRUCT-BENIGN/PREMALIG LESIONS^3^39
- +39 ;;^UTILITY(U,$J,358.4,332,0)
- +40 ;;=PARING/CUTTING^16^39
- +41 ;;^UTILITY(U,$J,358.4,333,0)
- +42 ;;=EXCISE BENIGN-SCALP/NECK/HAND/GENITAL/FT^5^39
- +43 ;;^UTILITY(U,$J,358.4,334,0)
- +44 ;;=EXCISE BENIGN-FACE/EAR/NOSE/LIP/LID^4^39
- +45 ;;^UTILITY(U,$J,358.4,335,0)
- +46 ;;=EXCISION BENIGN-TRUNK/ARM/LEG^6^39
- +47 ;;^UTILITY(U,$J,358.4,336,0)
- +48 ;;=EXCISE MALIG-FACE/EAR/NOSE/LIP/LID^7^39
- +49 ;;^UTILITY(U,$J,358.4,337,0)
- +50 ;;=EXCISE MALIG-SCALP/NECK/HAND/GENITAL/FT^8^39
- +51 ;;^UTILITY(U,$J,358.4,338,0)
- +52 ;;=EXCISION MALIG-TRUNK/ARM/LEG^9^39
- +53 ;;^UTILITY(U,$J,358.4,339,0)
- +54 ;;=REPAIR,SIMPLE-SCALP/NECK/TRUNK/EXTREM^21^39
- +55 ;;^UTILITY(U,$J,358.4,340,0)
- +56 ;;=REPAIR,SIMPLE-FACE/EAR/NOSE/LID/LIP^20^39
- +57 ;;^UTILITY(U,$J,358.4,341,0)
- +58 ;;=REPAIR,INTERMED-SCALP/TRUNK/LEG/ARM^19^39
- +59 ;;^UTILITY(U,$J,358.4,342,0)
- +60 ;;=REPAIR,INTERMED-FACE/EAR/NOSE/LID/LIP^17^39
- +61 ;;^UTILITY(U,$J,358.4,343,0)
- +62 ;;=REPAIR,INTERMED-NECK/HAND/GENITAL/FT^18^39
- +63 ;;^UTILITY(U,$J,358.4,344,0)
- +64 ;;=REPAIR-SIMPLE WOUND DEHISCENCE^22^39
- +65 ;;^UTILITY(U,$J,358.4,345,0)
- +66 ;;=NURSING PROCEDURES^14^39
- +67 ;;^UTILITY(U,$J,358.4,346,0)
- +68 ;;=BLOOD^2^39
- +69 ;;^UTILITY(U,$J,358.4,347,0)
- +70 ;;=IV INFUSION^11^39
- +71 ;;^UTILITY(U,$J,358.4,348,0)
- +72 ;;=MEDICATION^12^39
- +73 ;;^UTILITY(U,$J,358.4,349,0)
- +74 ;;=MEDICATION ADMINISTATION^13^39
- +75 ;;^UTILITY(U,$J,358.4,350,0)
- +76 ;;=PARACENTESIS^15^39
- +77 ;;^UTILITY(U,$J,358.4,351,0)
- +78 ;;=OTHER^23^39
- +79 ;;^UTILITY(U,$J,358.4,352,0)
- +80 ;;=ABDOMINAL PAIN^1^40
- +81 ;;^UTILITY(U,$J,358.4,353,0)
- +82 ;;=AFTERCARE POST SURGERY^2^40
- +83 ;;^UTILITY(U,$J,358.4,354,0)
- +84 ;;=BENIGN LESIONS OF SKIN^3^40
- +85 ;;^UTILITY(U,$J,358.4,355,0)
- +86 ;;=BREAST-FEMALE^5^40
- +87 ;;^UTILITY(U,$J,358.4,356,0)
- +88 ;;=BREAST-MALE^6^40
- +89 ;;^UTILITY(U,$J,358.4,357,0)
- +90 ;;=CARDIOVASCULAR^7^40
- +91 ;;^UTILITY(U,$J,358.4,358,0)
- +92 ;;=CIRRHOSIS^8^40
- +93 ;;^UTILITY(U,$J,358.4,359,0)
- +94 ;;=COLITIS^9^40
- +95 ;;^UTILITY(U,$J,358.4,360,0)
- +96 ;;=CROHN'S^10^40
- +97 ;;^UTILITY(U,$J,358.4,361,0)
- +98 ;;=DIVERTICULITIS^11^40
- +99 ;;^UTILITY(U,$J,358.4,362,0)
- +100 ;;=DIVERTICULOSIS^12^40
- +101 ;;^UTILITY(U,$J,358.4,363,0)
- +102 ;;=ENT^13^40
- +103 ;;^UTILITY(U,$J,358.4,364,0)
- +104 ;;=GANGLION^14^40
- +105 ;;^UTILITY(U,$J,358.4,365,0)
- +106 ;;=GANGRENE^15^40
- +107 ;;^UTILITY(U,$J,358.4,366,0)
- +108 ;;=GENERAL SIGNS/SYMPTOMS^16^40
- +109 ;;^UTILITY(U,$J,358.4,367,0)
- +110 ;;=GI^17^40
- +111 ;;^UTILITY(U,$J,358.4,368,0)
- +112 ;;=GYN^18^40
- +113 ;;^UTILITY(U,$J,358.4,369,0)
- +114 ;;=HEMORRHOIDS^19^40
- +115 ;;^UTILITY(U,$J,358.4,370,0)
- +116 ;;=INTESTINAL ABSCESS^20^40
- +117 ;;^UTILITY(U,$J,358.4,371,0)
- +118 ;;=LACERATION^21^40
- +119 ;;^UTILITY(U,$J,358.4,372,0)
- +120 ;;=MALIGNANT SKIN LESION^23^40
- +121 ;;^UTILITY(U,$J,358.4,373,0)
- +122 ;;=MELANOMA^24^40
- +123 ;;^UTILITY(U,$J,358.4,374,0)
- +124 ;;=MERKEL CELL CARCINOMA^25^40
- +125 ;;^UTILITY(U,$J,358.4,375,0)
- +126 ;;=OPEN WOUND^26^40
